---
title: "Troglitazone - Diabetes mellitus type 2 - 3"
sidebar: mydoc_sidebar
permalink: db00197-mesh-d003924-3.html
toc: false 
---


Path ID: `DB00197_MESH_D003924_3`
{% include image.html url="images/db00197-mesh-d003924-3.png" file="db00197-mesh-d003924-3.png" alt="db00197-mesh-d003924-3" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| DB:DB00197 | Troglitazone | Drug |
| UniProt:P37231 | Peroxisome proliferator-activated receptor gamma (PPAR-gamma) | Protein |
| InterPro:IPR000003 | 9-cis retinoic acid receptor (RXR [retinoid X receptor] | GeneFamily |
| GO:0030154 | Cell differentiation | BiologicalProcess |
| REACT:R-HSA-390918 | Lipid metabolism | Pathway |
| REACT:R-HSA-70326 | Glucose metabolism | Pathway |
| MESH:D001786 | Blood glucose | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Troglitazone | INCREASES ACTIVITY OF | Peroxisome Proliferator-Activated Receptor Gamma (Ppar-Gamma) |
| Peroxisome Proliferator-Activated Receptor Gamma (Ppar-Gamma) | MOLECULARLY INTERACTS WITH | 9-Cis Retinoic Acid Receptor (Rxr [Retinoid X Receptor] |
| 9-Cis Retinoic Acid Receptor (Rxr [Retinoid X Receptor] | POSITIVELY REGULATES | Cell Differentiation |
| Cell Differentiation | INCREASES ACTIVITY OF | Glucose Metabolism |
| Glucose Metabolism | DECREASES ABUNDANCE OF | Blood Glucose |
| Cell Differentiation | INCREASES ACTIVITY OF | Lipid Metabolism |
| Lipid Metabolism | DECREASES ABUNDANCE OF | Blood Glucose |
| Blood Glucose | MANIFESTATION OF | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Comment: Troglitazone was withdrawn in 2000 due to risk of hepatotoxicity

Reference: [https://go.drugbank.com/drugs/DB00197#mechanism-of-action](https://go.drugbank.com/drugs/DB00197#mechanism-of-action){:target="_blank"}